Skip to main content
Premium Trial:

Request an Annual Quote

Angle Raises Additional £2.8M in Share Placement

NEW YORK (GenomeWeb) – Liquid biopsy developer Angle announced today that it has raised £2.8 million ($3.7 million) through a subscription for approximately 7.5 million new ordinary shares at 37.5 pence each.

The deal represents a follow-on to the placement earlier this month of about 34.8 million new ordinary shares at 35 pence per share, which grossed £12.2 million. The company said that the further subscription was entered into in order to allow participation by an investor who was unable to complete the necessary paperwork in time for the original fundraising.

Angle Founder and CEO Andrew Newland said in a statement that the funding will help the company pursue commercial partnerships for its Parsortix circulating tumor cell system and close its previously announced £3.7 million acquisition of University of Toronto microarray spinout Axela.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.